Investment Rating - The report maintains a "Buy" rating for the company [4]. Core Insights - The company reported a revenue of 5.79 billion yuan in Q1 2025, representing a year-on-year increase of 7.6%. The net profit attributable to shareholders was 500 million yuan, up 5.8% year-on-year, while the net profit excluding non-recurring items was 480 million yuan, reflecting a 5.0% increase year-on-year [1]. - Core product categories showed positive growth, with online sales of rice cookers, pressure cookers, steamers, and health pots increasing by 0.43%, 7.91%, 6.66%, and 24.82% year-on-year, respectively. The company continues to implement a consumer-centric innovation strategy and product development strategy, leveraging big data to meet diverse consumer needs [1]. - The gross margin for Q1 2025 was 23.9%, a slight decrease of 0.5 percentage points year-on-year. The net profit margin was 8.6%, down 0.2 percentage points year-on-year [2]. Financial Projections - The company is projected to achieve net profits of 2.4 billion yuan, 2.55 billion yuan, and 2.7 billion yuan for the years 2025, 2026, and 2027, respectively, with year-on-year growth rates of 6.9%, 6.1%, and 6.0% [2]. - Revenue is expected to grow from 21.3 billion yuan in 2023 to 26.95 billion yuan in 2027, with a compound annual growth rate of approximately 6.4% [3]. - The latest diluted EPS is projected to increase from 2.72 yuan in 2023 to 3.37 yuan in 2027 [3]. Market Position - The company operates in the small home appliance industry and has a total market capitalization of approximately 44.59 billion yuan, with a closing price of 55.64 yuan as of April 24, 2025 [4]. - The company has a total share capital of 801.36 million shares, with 99.88% being freely tradable [4].

证券研究报告 | 年报点评报告 gszqdatemark 2025 04 25 年 月 日 巨人网络（002558.SZ） 征途 IP 产品持续扩圈，打造游戏+AI 生态图谱 事件：公司发布 2024 年年报，2024 年公司实现营业收入 29.23 亿元，同 比下滑 0.05%；实现归母净利润 14.25 亿元，同比增长 31.15%；实现扣 非归母净利润 16.23 亿元，同比增长 18.23%。公司年度利润分配预案拟 向全体股东每 10 股派发现金红利 1.40 元（含税）。 征途 IP 赛道：成熟产品实现用户扩圈，小程序端完成突破。2024 年，公 司上线多个季度资料片，2024 年 6 月的年度" 征途嘉年华"和 10 月的周 年庆典持续吸引核心玩家，强化了玩家对游戏的归属感。《原始征途》创新 地利用短剧这一新形式营销，形成 短剧+代言人"双驱动模式，精准契 合买量需求，传播辐射范围广泛，吸引大量潜在用户。爆款新游戏《王者 征途》凭借独特玩法设计与精准的市场定位，实现了小程序端的突破。"《王 者征途》自 2024 年 2 月上线小程序平台以来，成功引入超 2500 万新增 用户，全年贡献流水 6 亿 ...

Investment Rating - The investment rating for the company is "Buy" [6] Core Views - The company achieved a rapid revenue growth of 25.18% year-on-year in 2024, with total revenue reaching 2.066 billion yuan and a net profit of 673 million yuan, reflecting a growth of 26.08% [1] - The electrophysiology segment saw a significant increase in surgical volume, with over 15,000 procedures completed, marking a 50% year-on-year growth [3] - The company is benefiting from scale effects and changes in product structure, leading to an improvement in gross margin and a reduction in expense ratios [2] Financial Performance - In 2024, the company reported a revenue of 2.066 billion yuan, a 25.18% increase from the previous year, and a net profit of 673 million yuan, up 26.08% [1] - The first quarter of 2025 showed continued growth, with revenue of 564 million yuan, a 23.93% increase year-on-year, and a net profit of 183 million yuan, up 30.69% [1] - The gross margin for 2024 was 72.31%, an increase of 1.04 percentage points year-on-year, while the sales expense ratio improved to 18.05% [2] Business Segments - The electrophysiology segment generated revenue of 440 million yuan in 2024, growing by 19.73%, with a gross margin of 73.76% [2] - The coronary intervention segment saw revenue of 1.054 billion yuan, a 33.30% increase, with a gross margin of 73.21% [2] - The peripheral intervention segment reported revenue of 351 million yuan, up 37.09%, with a gross margin of 75.86% [2] - Non-vascular intervention revenue surged by 135.05% to 39 million yuan, with a gross margin of 59.89% [2] International Performance - The company achieved overseas revenue of 280 million yuan in 2024, a 19.62% increase, with overseas self-owned brands growing by 45.88% [4] - The company has made significant inroads into high-end hospitals in Spain, France, Italy, Germany, the UK, Switzerland, Turkey, and Brazil, enhancing its market penetration [4] Future Projections - Revenue projections for 2025-2027 are 2.694 billion yuan, 3.479 billion yuan, and 4.478 billion yuan, with year-on-year growth rates of 30.4%, 29.2%, and 28.7% respectively [4] - Net profit forecasts for the same period are 902 million yuan, 1.181 billion yuan, and 1.537 billion yuan, with growth rates of 34.0%, 30.9%, and 30.2% respectively [4]

Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [3][6]. Core Insights - The company demonstrates a strong competitive advantage in a declining profit environment for the industry, achieving higher profitability than the industry average [1][36]. - The company has established a self-sufficient breeding system, enhancing its market position and expected performance [2]. - The processing business is improving, with a focus on brand value enhancement and a dual-channel strategy [3]. Summary by Sections Company Overview - The company is the largest white feather chicken producer in Asia, with a complete supply chain covering feed processing, breeding, incubation, and meat processing [14]. Industry Context - The white feather chicken accounts for approximately 67% of the domestic chicken market, with slaughter volumes reaching 8.55 billion in 2024, a 3.6% increase year-on-year [28]. Profitability and Cost Management - The company has maintained a higher single-bird profit than the industry, with an estimated profit of 0.6 yuan per bird in 2024, despite overall industry profit declines [1][36]. - The company's chicken meat gross cost is projected at 8,939 yuan per ton in 2024, a 14% decrease year-on-year, reflecting effective cost management strategies [40][42]. Market Position and Expansion - The company has secured long-term strategic partnerships with major clients like Yum China and McDonald's, ensuring stable pricing and demand [1][3]. - Since 2018, the company has acquired quality assets, increasing its breeding capacity by 165 million birds and food processing capacity by 90,000 tons [1]. Breeding and Genetic Control - The company has achieved 100% self-sufficiency in breeding parent stock since 2019, with plans to increase its market share to 40% by the end of 2024, potentially adding 800 million yuan to its performance [2]. Processing Business Development - The company's food business is projected to generate 8.249 billion yuan in revenue in 2024, with a 3.7% year-on-year growth, although net profit is expected to decrease by 7% [3]. - The company is focusing on B2B and B2C segments, with B2B accounting for 79% of revenue and a strong emphasis on brand value enhancement [3]. Financial Projections - The company expects net profits of 993 million yuan, 1.06 billion yuan, and 1.21 billion yuan for 2025, 2026, and 2027, respectively, with growth rates of 37.1%, 6.8%, and 13.8% [3][5].

Investment Rating - The report maintains a "Buy" rating for the company [6] Core Views - The company reported a strong start in Q1 2025, with revenue of 6.25 billion yuan, a year-on-year increase of 5.1%, and a net profit attributable to shareholders of 840 million yuan, up 2.5% year-on-year [1] - The gypsum board segment faced a revenue decline of 6.1% year-on-year, attributed to intense industry competition, while the waterproof materials segment grew by 10.5% year-on-year [2] - The company is expanding its industrial coatings business, with plans to establish a production base in Anqing, Anhui Province, which will enhance its market competitiveness [2] Financial Performance - The company's gross margin for Q1 2025 was 28.9%, a slight increase of 0.3 percentage points year-on-year, while the net profit margin was 13.7%, a minor decrease of 0.3 percentage points [3] - Accounts receivable increased significantly by 93.9% compared to the beginning of the year, primarily due to the implementation of annual credit sales policies [3] - The company expects to achieve revenue of 28.865 billion yuan, 32.138 billion yuan, and 35.453 billion yuan for 2025, 2026, and 2027 respectively, with a compound annual growth rate of 8.3% [4] Business Segments - The gypsum board segment generated revenue of 4.28 billion yuan in Q1 2025, while the waterproof materials segment achieved 1.05 billion yuan, reflecting a robust growth trajectory [2] - The industrial coatings segment reported revenue of 908 million yuan, with plans for further expansion following the restructuring of the Carpoly business [2] Future Outlook - The company is expected to maintain a strong market position due to its cost advantages and brand strength, which will help mitigate price wars and protect profit margins [4] - The projected earnings per share (EPS) for 2025 is 2.71 yuan, with a price-to-earnings (P/E) ratio of 11 [5]

Investment Rating - The report maintains a "Buy" rating for the company [5] Core Views - The company achieved a revenue of 55.8 billion yuan in Q1 2025, a year-on-year increase of 14%, with a gross margin of 16% and a net profit of 3.54 billion yuan, reflecting a 59% year-on-year growth [1] - The increase in profit is attributed to comprehensive cost reduction and efficiency improvements, along with a year-on-year increase in production of key products [1] - The company is focusing on resource development and supply security, aiming to enhance its mining capacity and create a self-controlled mineral resource supply chain [2] - The company is advancing its "Two Seas" strategy, with new projects in alumina and electrolytic aluminum contributing to its competitive edge in the industry [3] - The company is expected to achieve net profits of 10.4 billion, 12.6 billion, and 14.9 billion yuan for 2025, 2026, and 2027 respectively, with corresponding P/E ratios of 10.7, 8.8, and 7.5 [3] Summary by Sections Financial Performance - In Q1 2025, alumina production reached 5.43 million tons, a 4% increase year-on-year, while electrolytic aluminum production was 1.94 million tons, up 9% year-on-year [1] - The average price of electrolytic aluminum in Q1 2025 was 20,400 yuan per ton, a 7.3% increase year-on-year, while alumina averaged 3,833 yuan per ton, a 15.2% increase year-on-year [1] - The company’s revenue for 2023 was 225.3 billion yuan, with a projected revenue of 222.3 billion yuan for 2025 [4] Strategic Initiatives - The company plans to increase its domestic mineral rights exploration and actively participate in the competition for mineral rights in key provinces [2] - New projects include the construction of several alumina and aluminum alloy projects, as well as renewable energy initiatives, with a target of achieving a 45.5% clean energy consumption ratio in electrolytic aluminum production [3] Valuation Metrics - The report provides projected earnings per share (EPS) of 0.60 yuan for 2025, with a net asset return rate of 13.6% [4] - The company’s total market capitalization is approximately 111.17 billion yuan, with a total share count of 17.16 billion shares [5]

Investment Rating - The report maintains a "Buy" rating for the company [4]. Core Insights - The company reported a revenue of 5.79 billion yuan in Q1 2025, representing a year-on-year increase of 7.6%. The net profit attributable to shareholders was 500 million yuan, up 5.8% year-on-year, while the net profit excluding non-recurring items was 480 million yuan, reflecting a 5.0% increase year-on-year [1]. - The core product categories showed positive growth, with online sales of rice cookers, pressure cookers, steamers, and health pots increasing by 0.43%, 7.91%, 6.66%, and 24.82% year-on-year, respectively. The company continues to implement a consumer-centric innovation strategy and product development strategy, leveraging big data to meet diverse consumer needs [1]. Financial Performance Summary - In Q1 2025, the company's gross margin was 23.9%, a decrease of 0.5 percentage points year-on-year. The net profit margin was 8.6%, down 0.2 percentage points year-on-year [2]. - The company forecasts net profits for 2025, 2026, and 2027 to be 2.4 billion, 2.55 billion, and 2.7 billion yuan, respectively, with year-on-year growth rates of 6.9%, 6.1%, and 6.0% [2]. - The projected revenue for 2025 is 23.823 billion yuan, with a year-on-year growth rate of 6.2% [3]. Stock Information - The company's market capitalization is approximately 44.59 billion yuan, with a closing price of 55.64 yuan as of April 24, 2025 [4]. - The company has a total share capital of 801.36 million shares, with 99.88% being freely tradable [4]. Valuation Metrics - The report provides a P/E ratio of 18.6 for 2025, which is expected to decrease to 16.5 by 2027. The P/B ratio is projected to decline from 6.5 in 2025 to 5.6 in 2027 [3]. - The latest diluted EPS is forecasted to be 2.99 yuan in 2025, increasing to 3.37 yuan by 2027 [3].

Investment Rating - The investment rating for the company is "Buy" [4] Core Views - The company is expected to show exceptional growth performance in 2025, with a projected revenue increase of 5.6% to 48.12 billion yuan and a net profit growth of 20% to 5.2 billion yuan [8] - The company faced a revenue decline of 14.2% in 2024, primarily due to losses in its U.S. furniture business, but domestic home textile operations are expected to improve [7][8] - The company maintains a healthy inventory quality and continues to improve operational efficiency, setting a solid foundation for growth in 2025 [7][8] Summary by Sections Financial Performance - In 2024, the company's revenue decreased by 14.2% to 45.6 billion yuan, with a net profit decline of 24.4% to 4.3 billion yuan [1] - The gross margin improved by 0.7 percentage points to 48% due to effective cost control [1] - The company declared a total dividend of 0.6 yuan per share for the year, resulting in a dividend payout ratio of 115.48% and a dividend yield of 7.2% based on the closing price on April 24 [1] Direct Sales Channel - Revenue from direct sales decreased by 1.48% to 400 million yuan in 2024, but the gross margin increased by 0.3 percentage points to 67.55% [2] - The average annual sales per direct store fell by 19.7% to 976,500 yuan, indicating pressure on customer traffic [2] Franchise Channel - Franchise revenue dropped by 19.03% to 1.45 billion yuan in 2024, while the gross margin increased by 1.42 percentage points to 48.84% [3] - The company closed 168 underperforming franchise stores, reducing the total to 2,227 [3] E-commerce Channel - E-commerce revenue declined by 14.12% to 1.38 billion yuan, but the gross margin improved by 1.11 percentage points to 53.32% [3] - The company is focusing on maintaining profitability in e-commerce by controlling discounts [3] U.S. Business - The U.S. business saw a revenue decline of 21.54% to 820 million yuan, resulting in a loss of approximately 28.71 million yuan [7] - The company anticipates that the current economic environment and tariff policies in the U.S. will remain uncertain [7] Future Outlook - The company expects to gradually launch its smart industrial park in 2025, which will enhance production efficiency and overall operational capabilities [8] - The projected earnings for 2025-2027 are 5.2 billion yuan, 5.75 billion yuan, and 6.22 billion yuan respectively, with a price-to-earnings ratio of 13 times for 2025 [8][9]

Investment Rating - The investment rating for the company is "Buy" [6] Core Views - The company achieved a rapid revenue growth of 25.18% year-on-year in 2024, with a total revenue of 2.066 billion yuan and a net profit of 673 million yuan, reflecting a growth of 26.08% [1] - The electrophysiology segment saw a significant increase in surgical volume, with over 15,000 procedures performed, marking a 50% year-on-year growth [3] - The company is experiencing strong performance in overseas markets, with a 45.88% increase in overseas self-owned brand revenue, particularly in the Middle East, Africa, and Europe [4] Financial Performance Summary - In 2024, the company reported total revenue of 20.66 billion yuan, a 25.18% increase from the previous year, and a net profit of 6.73 billion yuan, up 26.08% [1] - The revenue breakdown by business segment for 2024 includes: - Electrophysiology: 440 million yuan (up 19.73%), gross margin 73.76% - Coronary intervention: 1.054 billion yuan (up 33.30%), gross margin 73.21% - Peripheral intervention: 351 million yuan (up 37.09%), gross margin 75.86% - Non-vascular intervention: 39 million yuan (up 135.05%), gross margin 59.89% [2] - The company expects revenue growth of 30.4%, 29.2%, and 28.7% for 2025, 2026, and 2027, respectively, with net profits projected to grow by 34.0%, 30.9%, and 30.2% in the same years [4] Operational Highlights - The company expanded its electrophysiology product coverage to over 1,360 hospitals, with a significant increase in the number of procedures performed [3] - The vascular intervention segment led the growth, with coronary product admissions increasing by over 15% and peripheral product admissions by nearly 20% [3] - The company hosted over 150 self-brand events across more than 20 provinces, enhancing brand recognition and market penetration [4]

打造游戏+AI 生态图谱，AI 玩法探索多点开花。公司于 2024 年底的中 国游戏产业年会上发布" 千影 QianYing"有声游戏生成大模型，实现了有 声可交互游戏视频生成的新突破。千影大模型包含 YingGame 视频生成大 模型与 YingSound 视频配音大模型。YingGame 作为开放世界游戏视频生 成大模型，结合视频配音大模型 YingSound 的精准音效生成能力，实现了 有声可交互游戏视频生成的新突破。千影的发布意味着公司实现了自研大 语言模型、语音大模型与视频大模型的多模态全矩阵布局。2024 年，公司 基于 GiantGPT 为《征途》系列游戏打造了陪伴型智能 NPC，助力提升玩 家粘性。"《太空杀》业业内早深深 AI 原生玩法的游戏产品，陆续推出了 推理剧场"、 残局挑战"和 内鬼挑战"等功能模式。其中， AI 残局 挑战"业业内首个基于多智能体大模型（Multi-Agent LLM）打造的 AI 原 生玩法，以 1 个真人玩家+N 个 AI 玩家"的模式展开。 盈利预测：公司征途 IP 产品与休闲竞技产品表现优异，全球化战略持续 推进，AI 应用降本增效。预计 2025-2027 ...